Interim results of the international multicenter prospective observational study to evaluate the epidemiology, humanistic and economic outcomes of...
Чуланов В. П., Исаков В. А., Жданов К. В., Бакулин И. Г., Бурневич Э. З., Латарска-Смуга Д.
Инфекционные болезни
Т. 16, Вып. 1, С. 5-14
Опубликовано: 2018
Тип ресурса: Статья
DOI:10.20953/1729-9225-2018-1-5-14
Аннотация:
The objective. To study clinico-epidemiological characteristics of patients with CHC and to evaluate clinical, economic and other parameters related to their treatment. Patients and methods. The study is conducted in 10 countries in Central and Eastern Europe involving 1.500-2000 patients with chronic HCV infection, aged 18 years and older not current receiving treatment for hepatitis and seeking for care in a routine clinical visit to physician. After enrollment, patients are observed until the end of HCV treatment. The study includes three consecutive phases. At the phase 1 epidemiological data for the patients seeking for care is being collected at the single visit. Patients for whom antiviral IFN-containing treatment is planned to be started within 12 weeks from the first visit were included into the second phase. During phase 2 patients are being assessed on-treatment for HRQoL changes over time, the impact of HCV and treatment on work productivity, activities of daily living and
Ключевые слова:
Chronic hepatitis C; Liver cirrhosis; Pegylated interferon alfa; Treatment outcome
Язык текста: Русский
ISSN: 2414-9691
Чуланов В. П. Владимир Петрович 1970-
Исаков В. А.
Жданов К. В.
Бакулин И. Г.
Бурневич Э. З. Эдуард Збигневич 1972-
Латарска-Смуга Д.
Chulanov V. P. Vladimir Petrovich 1970-
Isakov V. A.
Zhdanov K. V.
Bakulin I. G.
Burnevich E`. Z. E`duard Zbignevich 1972-
Latarska-Smuga D.
Interim results of the international multicenter prospective observational study to evaluate the epidemiology, humanistic and economic outcomes of treatment for chronic hepatitis C virus (HCV) (MOSAIC)
Interim results of the international multicenter prospective observational study to evaluate the epidemiology, humanistic and economic outcomes of...
Текст визуальный непосредственный
Инфекционные болезни
ООО "Издательство "Династия"
Т. 16, Вып. 1 С. 5-14
2018
Статья
Chronic hepatitis C Liver cirrhosis Pegylated interferon alfa Treatment outcome
The objective. To study clinico-epidemiological characteristics of patients with CHC and to evaluate clinical, economic and other parameters related to their treatment. Patients and methods. The study is conducted in 10 countries in Central and Eastern Europe involving 1.500-2000 patients with chronic HCV infection, aged 18 years and older not current receiving treatment for hepatitis and seeking for care in a routine clinical visit to physician. After enrollment, patients are observed until the end of HCV treatment. The study includes three consecutive phases. At the phase 1 epidemiological data for the patients seeking for care is being collected at the single visit. Patients for whom antiviral IFN-containing treatment is planned to be started within 12 weeks from the first visit were included into the second phase. During phase 2 patients are being assessed on-treatment for HRQoL changes over time, the impact of HCV and treatment on work productivity, activities of daily living and